These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 7609360

  • 1. [Clinical results of IV-compa (cisplatin, vincristine, methotrexate, peplomycin and adriamycin) chemotherapy for advanced urothelial cancer].
    Tsujino S, Ono Y, Yamamoto S, Tsuzuki M, Miki M, Aizawa T, Matsumoto T, Yamauchi T.
    Nihon Hinyokika Gakkai Zasshi; 1995 Jun; 86(6):1164-71. PubMed ID: 7609360
    [Abstract] [Full Text] [Related]

  • 2. [Intraarterial COMPA (cis-diammine-dichloroplatinum (II), vincristine, methotrexate, peplomycin, adriamycin) chemotherapy for bladder cancer].
    Tsujino S, Ito T, Aizawa T, Namiki K, Ohno Y, Yamamoto S, Ishibashi K, Miki M, Yamauchi T, Kawai T.
    Hinyokika Kiyo; 1992 Oct; 38(10):1101-7. PubMed ID: 1282770
    [Abstract] [Full Text] [Related]

  • 3. [Intra-arterial COMPA chemotherapy for invasive bladder cancer].
    Tsujino S, Yamauchi T, Kokuho M, Kobayashi T, Tachibana Y, Sawano S, Kawai T.
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1640-6. PubMed ID: 1279259
    [Abstract] [Full Text] [Related]

  • 4. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T, Hida S, Ooishi K, Okada K, Yoshida O.
    Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
    [Abstract] [Full Text] [Related]

  • 5. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
    Konami T, Wakabayashi Y, Kim T, Ishida A, Arai Y, Konishi T, Pak K, Takeuchi H, Tomoyoshi T, Watanabe J.
    Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results.
    Kuroiwa T, Naito S, Hasuo K, Kishikawa T, Masuda K, Kumazawa J.
    Cancer Chemother Pharmacol; 1995 Feb; 35(5):357-63. PubMed ID: 7850915
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancer.
    Bellmunt J, Cos J, Clèries R, Pérez M, Ribas A, Eres N, Murio JE, Margarit C, Baselga J.
    Cancer Invest; 2002 Feb; 20(5-6):673-85. PubMed ID: 12197223
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Adjuvant chemotherapy with MVP-CAB (methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin and bleomycin) for epithelial tumors of the upper urinary tract].
    Fujii A, Oka N, Murata Y, Higuchi A, Itoh N, Ishikawa J, Tanaka H.
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1609-14. PubMed ID: 1279258
    [Abstract] [Full Text] [Related]

  • 13. [Combination chemotherapy with methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin, and bleomycin (MVP-CAB) for metastatic urothelial cancer].
    Fujii A, Oka N, Miyasaki S, Higuchi A, Itoh N, Okamoto Y, Tanaka H, Hiro-oka K, Shimatani N, Inoue T.
    Nihon Hinyokika Gakkai Zasshi; 1991 Jun; 82(6):932-9. PubMed ID: 1715415
    [Abstract] [Full Text] [Related]

  • 14. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)].
    Fujioka H, Tada Y, Nakano E, Matsuda M, Osafune M, Sagawa S, Takaha M, Sonoda T.
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1612-6. PubMed ID: 6541019
    [Abstract] [Full Text] [Related]

  • 15. [Combination chemotherapy with methotrexate (MTX), vincristine (VCR), cisplatinum (CDDP), cyclophosphamide (CPM), adriamycin (ADM), and bleomycin (BLM); MVP-CAB in patients with advanced urothelial tract cancer].
    Fujii A, Morishita S, Nakamura I, Oka Y, Ohshima H, Nagata H, Iwamoto T, Izumi T, Miyasaki Z, Ito N.
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):985-93. PubMed ID: 2460657
    [No Abstract] [Full Text] [Related]

  • 16. [Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer].
    Hashimura T, Okumura K, Akao T, Nakagawa T.
    Hinyokika Kiyo; 1991 Jul; 37(7):685-8. PubMed ID: 1927767
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter.
    Czito B, Zietman A, Kaufman D, Skowronski U, Shipley W.
    J Urol; 2004 Oct; 172(4 Pt 1):1271-5. PubMed ID: 15371822
    [Abstract] [Full Text] [Related]

  • 18. [Combined therapy with 5-fluorouracil, doxorubicin, cis-diamminedichloroplatinum on advanced urothelial cancer].
    Kawai T, Washizuka M, Kihara K, Takahashi T, Sakata Y, Tai K, Nagayama T, Okada K, Kusuyama H, Ishii Y.
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb 20; 22(1):40-6. PubMed ID: 3611890
    [No Abstract] [Full Text] [Related]

  • 19. [Therapeutic experiences of cis-diamminedichloroplatinum, adriamycin and 5-fluorouracil combination chemotherapy in advanced urothelial cancer, with special reference to adjuvant chemotherapy in invasive urothelial cancer].
    Ogawa O, Yoshimura N, Taniguchi T, Nishimura K, Nakagawa T.
    Hinyokika Kiyo; 1986 Jun 20; 32(6):795-802. PubMed ID: 3766338
    [Abstract] [Full Text] [Related]

  • 20. Chemotherapy with methotrexate, carboplatin, mitoxantrone (Novantrone) and vincristine (Oncovin) in transitional-cell urothelial cancer.
    Pectasides D, Mylonakis A, Antoniou F, Kostopoulou M, Triantaphyllis D, Papadopoulou M, Varthalitis J, Dimitriadis M, Athanassiou A.
    Oncology; 1998 Jun 20; 55(2):139-44. PubMed ID: 9499188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.